Dudediligence.

Vaxcyte, Inc

PCVXNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$103.1MSep ’24−$137.1MDec ’24−$140.7MMar ’25−$166.6MJun ’25−$212.8MSep ’25$519.4MDec ’25−$320.6MMar ’26−$284.3MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$103.7M−$232.3M−$468.0M−$569.5M−$923.7M
Net income−$100.1M−$223.5M−$402.3M−$463.9M−$766,628
Operating cash flow−$121.4M−$170.6M−$296.8M−$452.6M−$655.6M
Free cash flow−$127.9M−$176.4M−$312.9M−$475.1M−$669.3M
Cash$69.0M$834.7M$397.5M$387.9M$174.0M
Shares outstanding53.0M79.5M95.4M124.9M131.1M